Fora Capital, LLC Alkermes Plc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $547,657 - $627,934	21,638 New	21,638 $609,000
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $28,184 - $38,748	-1,206 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $3,324 - $4,451	-177 Reduced 12.8%	1,206 $30 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $316,835 - $403,656	-17,399 Reduced 92.64%	1,383 $26 Million
Q4 2020 Feb 12, 2021	BUY	$15.39 - $22.1 $289,054 - $415,082	18,782 New	18,782 $374,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.